GLP-1 receptor drugs may help or harm weight control and eating disorders

GLP-1 receptor agonists may reduce binge-eating episodes but also raise concerns due to psychiatric adverse effects.

• Evidence supporting the appetite-suppressing effects of GLP-1 receptor agonists is limited and inconsistent, often derived from small trials.
• Some patients have reported reductions in binge-eating episodes when using GLP-1 receptor agonists.
• Psychiatric adverse effects, including anxiety and depression, have been noted in individuals taking these medications.
• Extreme appetite suppression and pathological dietary restrictions have been associated with GLP-1 receptor agonist therapy.
• GLP-1 receptor agonists may affect brain reward pathways, complicating their influence on eating behaviors.
• Caution is necessary when prescribing GLP-1 receptor agonists to individuals with a history of eating disorders.

Simplified